Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.88M Buy
80,000
+55,742
+230% +$6M 0.02% 800
2026
Q1
$2.49M Buy
+24,258
New +$2.47M ﹤0.01% 1479
2025
Q3
Sell
-54,732
Closed -$4.18M 2389
2025
Q2
$4.18M Sell
54,732
-20,424
-27% -$1.49M 0.01% 1126
2025
Q1
$5.33M Sell
75,156
-3,580
-5% -$280K 0.01% 995
2024
Q4
$6.16M Buy
78,736
+41,447
+111% +$3.87M 0.02% 940
2024
Q3
$3.81M Sell
37,289
-81,207
-69% -$6.74M 0.01% 1118
2024
Q2
$8.99M Buy
+118,496
New +$8.43M 0.02% 748
2024
Q1
Sell
-6,988
Closed -$514K 2228
2023
Q4
$514K Buy
+6,988
New +$432K ﹤0.01% 1669

Other funds holding NUVL

Man Group's NUVL Position: Q2 2026 in Review

Man Group increased its Nuvalent (NUVL) stake by 230% in Q2 2026, buying an estimated $6M and bringing the position to 80,000 shares worth $9.88M. The position accounts for 0.02% of the portfolio, ranked #800.

Man Group first reported a position in NUVL in Q4 2023 and has held it in 8 quarters since. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Man Group held 80,000 shares of Nuvalent worth $9.88M as of Q2 2026.
  • Man Group bought 55,742 Nuvalent shares in Q2 2026, an estimated $6M.
  • Nuvalent made up 0.02% of Man Group's portfolio in Q2 2026, its #800 holding.
  • Man Group first reported a position in Nuvalent in Q4 2023 and has held it in 8 quarters since.
  • 293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.